person

Charles F.

Country
France
Department
Service de Cardiologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
117
Sites with multiple studies

Has run more than one trial at 117 of 499 partner sites.

Specializations

Cardiovascular Disease Management

The investigator specializes in treating patients with heart failure, particularly focusing on novel therapeutic approaches for those with impaired kidney function. Their research encompasses the evaluation of combination therapies involving balcinrenone and dapagliflozin for cardiovascular outcomes.

  • Heart Failure Treatment
  • Cardiorenal Syndrome
  • Cardiovascular Death Prevention

Their expertise extends to managing complex cases where heart failure coexists with renal complications.

Innovative Therapeutic Solutions

The investigator conducts research on emerging treatments for heart failure patients with reduced left ventricular ejection fraction. Their work includes evaluating novel compounds like XXB750 and their effects on cardiac biomarkers such as NT-proBNP.

  • Biomarker Assessment
  • Dose-Response Studies
  • Standard of Care Optimization

Their research focuses on patients receiving contemporary heart failure therapies including ACE inhibitors and ARBs.

Treatment Optimization Studies

The investigator explores treatment optimization strategies, particularly in patients with recovered left ventricular ejection fraction. Their research evaluates the safety and efficacy of discontinuing beta-blocker therapy in specific patient populations.

  • Beta-Blocker Management
  • Heart Failure Recovery
  • Cardiovascular Outcomes

Their work includes differentiated approaches for ischemic and non-ischemic heart failure etiologies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.